Molecular Diagnostics
New Test Identifies Women Less Likely to Respond to Standard Breast Cancer Treatment
Scientists have identified a set of new ‘biomarkers’ – or biological markers – that are associated with poor response to drugs called aromatase inhibitors, in patients with ER+/HER2+ breast cancers. The findings are significant in their potential to guide future treatment for women with ER+/HER2+ tumors. More...03 Nov 2022
New Test Detects Antibodies Responsible for Thromboses and Miscarriages
Antiphospholipid syndrome (APS) is an auto-immune disease that can cause miscarriages or the death of the fetus. Researchers have now created the best possible target molecule for the antibodies responsible for APS, enabling a new screening test to be developed. More...02 Nov 2022
New Molecular Diagnostic System to Expand Access to PCR Testing in the U.S.
Roche Diagnostics (Basel, Switzerland) has announced plans for the U.S. launch of the cobas 5800 System, a compact, fully-automated molecular laboratory instrument that offers a flexible, PCR testing solution that aids clinicians in diagnosis of infectious diseases. More...02 Nov 2022
Novel Nanopore-Based Technology Rapidly and Precisely Detects Pathogens for Cancer Patients
Immunocompromised cancer patients are prone to be infected by various microbes and have an elevated mortality rate compared with other infected patients. Researchers have now developed a new method based on nanopore-based technology for rapidly detecting microbes from cancer patients. More...02 Nov 2022
Blood Test Accurately Diagnoses Early-Stage Osteoarthritis
Researchers have developed a blood test for diagnosis of early-stage osteoarthritis, marking an important breakthrough as early detection of arthritis enables treatment and support to be given before irreversible damage to the joints has occurred. More...31 Oct 2022
Next-Gen Whole Blood DNA Collection and Extraction Kit to Introduce Cutting-Edge Capabilities
A next generation whole blood DNA collection and extraction kit under development aims to introduce cutting-edge capabilities that could have a significant impact on precision medical research. More...27 Oct 2022
Liquid Biopsies Can Identify Cancer Patients at Higher Risk of Developing Additional Blood Cancers
Researchers have found that liquid biopsies, which are increasingly used in the routine care of patients to identify and monitor the progress of cancer, can also detect clonal haematopoiesis (CH), a disorder of blood cells that places patients at higher risk of developing blood cancers. More...27 Oct 2022
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
New
Free Human Prostate-Specific Antigen CLIA
LIAISON fPSA
New
PSA Test
Human Semen Rapid Test
In Other News
World’s First Portable, High Yield Sequencer Provides Comprehensive DNA Analysis for Anyone, Anywhere
Diagnostic Tool Applies Machine Learning to Identify and Predict Sepsis Cases
Hematological Neoplasm Cytogenetics Profiled With Optical Genome Mapping
Super-Enhancer Induces Oncogenic Driver in Colorectal Carcinoma
Simple Blood Test Could Offer Smarter Treatment for Children’s Cancer
AI Diagnostic Tool Could Deliver Results in Two Minutes Using Fingertip Sample
Swab Test Identifies Dangerous Cervical Cell Changes Years Before They Occur
Periodontal Rapid Diagnostic Test Could Calculate Risk for Heart and Lung Disease
AI-Based Prenatal Blood Test Identifies Dangerous Fetal Heart Defects before Birth
Gene Expression Profiling of Mucinous Ovarian Tumors Identifies Prognosis Markers
Link Identified Between Mitochondria and Pancreatic Cancer Risk
Nucleic Acid Amplification Technology to Help Develop Instrument-Free Assays
Fecal Immunochemical Test a Less Expensive Alternative for Colorectal Cancer Screening
Direct-From-Blood Molecular Diagnostic Test to Rapidly Detect Early Lyme Disease
Oncology Test Integration with EMR to Simplify MRD Testing Workflows
New Testing Method Simplifies Tuberculosis Diagnosis
Rapid Blood Test Predicts Organ Transplant Rejection in Six Hours
Levels of Circulating Cell-Free DNA Predict Risk of Developing Dementia
Molecular IVD Assay Identifies Women at High Risk for Cervical Cancer
Rapid Diagnostic Tool to Revolutionize Diagnosis of Tick-Borne Diseases
Fragile X Syndrome Mutations Found With Comprehensive Testing Method
Genetic Prognosis Explored for Pediatric Dilated Cardiomyopathy
Highly Sensitive Biosensing Technology Diagnoses Alzheimer’s Disease in Blood
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.